Combination immunotherapy helps overcome melanoma treatment resistance
Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.
Nov 7, 2025
0
0